CLINICAL AND LABORATORY FEATURES OF HHV-6 INFECTION IN IMMUNOCOMPROMISED CHILDREN FOLLOWED UP AT THE CHILDREN’S POLYCLINIC

I. I Lvova , A. V Deryusheva , N. S. Legotina , E. V Sidor

Epidemiology and Infectious Diseases ›› 2013, Vol. 18 ›› Issue (4) : 35 -39.

PDF
Epidemiology and Infectious Diseases ›› 2013, Vol. 18 ›› Issue (4) : 35 -39. DOI: 10.17816/EID40742
Articles
research-article

CLINICAL AND LABORATORY FEATURES OF HHV-6 INFECTION IN IMMUNOCOMPROMISED CHILDREN FOLLOWED UP AT THE CHILDREN’S POLYCLINIC

Author information +
History +
PDF

Abstract

In a cohort of 100 immunocompromised children aged 3 months to 12 years in continuous screening of saliva and urine with a qualitative polymerase chain reaction (PCR) assay DNA herpes virus 4, 5, 6, type (CMV, EBV, HHV-6) were verified in 76% of cases. DNA herpes virus type 6 was detected significantly more often (56%). On the material of the primary medical documentation and data of clinical and laboratory examination in conditions of a children's polyclinic there was performed the analysis of clinical and epidemiological risk factors for intrauterine infection (IUI), and clinical and laboratory markers of secondary immune deficiency (SID). It was made a suggestion about predominant vertical transmission of HHV-6 during the antenatal period. Based on 100 percent of detection of opportunistic herpes viral DNA in children aged 1-3 years the tactics of "antigenic sparing" in young children with SID was justified. To optimize the diagnostic measures in respect of immunocompromised children in conditions of a children's polyclinic the performance of a comprehensive screening PCR testing for HSV infections, including HHV-6, as well as immunological and bacteriological control is proposed.

Keywords

herpes virus type 6 / children / secondary immune deficiency

Cite this article

Download citation ▾
I. I Lvova, A. V Deryusheva, N. S. Legotina, E. V Sidor. CLINICAL AND LABORATORY FEATURES OF HHV-6 INFECTION IN IMMUNOCOMPROMISED CHILDREN FOLLOWED UP AT THE CHILDREN’S POLYCLINIC. Epidemiology and Infectious Diseases, 2013, 18(4): 35-39 DOI:10.17816/EID40742

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Абатуров А.Е., Шостакович-Корецкая Л.П. HHV-6 инфекция у детей. Днепропетровская государственная медицинская академия. Инфекции у детей. 2007; 3: 89.

[2]

Caserta M.T., McDermott M.P., Dewhurst S., Schnabel K., Carnahan J.A., Gilbert L. et al. Human herpesvirus 6 (HHV6) DNA persistens and reactivation in healthy children. J. Pediatr. 2004; 145 (4): 478-84.

[3]

Симованьян Э.Н., ред. Инфекционные болезни у детей: Учебное пособие. Ростов н/Д: Феникс; 2011.

[4]

Казанцева Е.С., Заводова Н.Б., Пилипенко О.В. Наумова И.В., Любавина А.Е. Морфологические и молекулярнобиологические сопоставления при диагностике инфекций, вызванных HHV-6. В кн.: Труды V Съезда Российского общества детских патологов. СПб.; 2012: 134-9.

[5]

КазмирчукВ.Е., Мальцев Д.В. Диагностика и лечение инфекции, вызванной вирусом герпеса человека 6-го типа. Клиническая иммунология, аллергология, инфектология. 2011; 5: 33-40.

[6]

Львова И.И. Повышение эффективности активной иммунизации против дифтерии и кори у детей с синдромом нарушения противоинфекционной защиты: Автореф. дис.. д-ра мед. наук. Пермь; 2004.

[7]

Новиков М.Ю. Последствия тяжелых форм внутриутробной инфекции у детей раннего возраста: Автореф. дис.. канд. мед. наук. Пермь; 2011.

[8]

Ярцева М.Н., Яковлева К.П., Плахтиенко М.В. Иммунная недостаточность и часто болеющие дети. Сonsilium Medicum. 2006; 8 (1).

RIGHTS & PERMISSIONS

Eco-vector

AI Summary AI Mindmap
PDF

140

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/